A take over offer at premium price $1.20 - $1.50 won't be surprising by end of the year for ground breaking technology that will replace the traditional detection of bronchiolitis. I believe the break through will be rightly awarded for 4DMedical’s XV Technology® in right time. Even 5% market share (from $31B) market will place 4DX at $1B MC. I believe SP at current level is significantly undervalued.
A take over offer at premium price $1.20 - $1.50 won't be...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.005(1.14%) |
Mkt cap ! $182.6M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 46.5¢ | 44.5¢ | $118.5K | 261.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23629 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 230601 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |